Suparna Nanua

807 total citations
16 papers, 640 citations indexed

About

Suparna Nanua is a scholar working on Molecular Biology, Physiology and Immunology. According to data from OpenAlex, Suparna Nanua has authored 16 papers receiving a total of 640 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Physiology and 5 papers in Immunology. Recurrent topics in Suparna Nanua's work include Virus-based gene therapy research (3 papers), Immune Cell Function and Interaction (3 papers) and Asthma and respiratory diseases (3 papers). Suparna Nanua is often cited by papers focused on Virus-based gene therapy research (3 papers), Immune Cell Function and Interaction (3 papers) and Asthma and respiratory diseases (3 papers). Suparna Nanua collaborates with scholars based in United States, Pakistan and Armenia. Suparna Nanua's co-authors include Marc B. Hershenson, Uma S. Sajjan, Qiong Wang, J. Kelley Bentley, Umadevi Sajjan, Andrea N. Faris, Adam T. Comstock, Shyamala Ganesan, Dawn C. Newcomb and Adam M. Goldsmith and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Suparna Nanua

16 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suparna Nanua United States 9 196 154 145 140 119 16 640
Kenichi Sakamoto Japan 14 153 0.8× 61 0.4× 51 0.4× 104 0.7× 204 1.7× 101 958
Richard Allan United Kingdom 14 72 0.4× 80 0.5× 109 0.8× 127 0.9× 105 0.9× 39 661
Vincent van Laak Germany 15 585 3.0× 245 1.6× 176 1.2× 95 0.7× 416 3.5× 18 1.1k
Hongtao Li China 15 211 1.1× 203 1.3× 114 0.8× 219 1.6× 145 1.2× 31 817
Yehudit Bergman United States 26 290 1.5× 241 1.6× 92 0.6× 90 0.6× 612 5.1× 56 1.7k
Yinuo Gu China 12 145 0.7× 174 1.1× 116 0.8× 65 0.5× 245 2.1× 16 635
Sumeet Pandey United Kingdom 10 346 1.8× 201 1.3× 39 0.3× 167 1.2× 649 5.5× 11 1.1k
Shanjana Awasthi United States 19 341 1.7× 186 1.2× 283 2.0× 53 0.4× 270 2.3× 50 896
S Nagao Japan 15 515 2.6× 185 1.2× 240 1.7× 61 0.4× 249 2.1× 29 1.0k
Jay B. Hilliard United States 11 194 1.0× 180 1.2× 915 6.3× 230 1.6× 295 2.5× 13 1.3k

Countries citing papers authored by Suparna Nanua

Since Specialization
Citations

This map shows the geographic impact of Suparna Nanua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suparna Nanua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suparna Nanua more than expected).

Fields of papers citing papers by Suparna Nanua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suparna Nanua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suparna Nanua. The network helps show where Suparna Nanua may publish in the future.

Co-authorship network of co-authors of Suparna Nanua

This figure shows the co-authorship network connecting the top 25 collaborators of Suparna Nanua. A scholar is included among the top collaborators of Suparna Nanua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suparna Nanua. Suparna Nanua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Nanua, Suparna, et al.. (2022). AML with BCR-ABL1 Fusion treated with Imatinib, a Hypomethylating Agent and Venetoclax. Leukemia Research Reports. 17. 100333–100333. 1 indexed citations
2.
Masood, Ashiq, Samia Asif, Leyla Shune, et al.. (2021). Non-secretory multiple myeloma with unusual TFG-ALK fusion showed dramatic response to ALK inhibition. npj Genomic Medicine. 6(1). 23–23. 6 indexed citations
3.
Nanua, Suparna, et al.. (2020). Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia. SHILAP Revista de lepidopterología. 2(1). 20–22. 1 indexed citations
4.
Kapuria, Devika, et al.. (2016). A Case ofDe NovoCD5+ Disseminated Intravascular Large B-Cell Lymphoma Presenting as Multiorgan Failure. SHILAP Revista de lepidopterología. 2016. 1–5. 4 indexed citations
5.
Ganesan, Shyamala, Andrea N. Faris, Adam T. Comstock, et al.. (2012). Quercetin inhibits rhinovirus replication in vitro and in vivo. Antiviral Research. 94(3). 258–271. 156 indexed citations
6.
Nanua, Suparna, Mark A. Murakami, Jun Xia, et al.. (2011). Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood. 117(13). 3539–3547. 60 indexed citations
7.
Nanua, Suparna, Nancy L. Bartlett, Anjum Hassan, et al.. (2011). Composite diffuse large B-cell lymphoma and precursor B lymphoblastic lymphoma presenting as a double-hit lymphoma with MYC and BCL2 translocation. Journal of Clinical Pathology. 64(11). 1032–1034. 6 indexed citations
8.
Nanua, Suparna, et al.. (2009). Performance Evaluation of the VersaTREK Blood Culture System for Quality Control Testing of Platelet Units. Journal of Clinical Microbiology. 47(3). 817–818. 8 indexed citations
9.
Newcomb, Dawn C., Umadevi Sajjan, Deepti R. Nagarkar, et al.. (2008). Human Rhinovirus 1B Exposure Induces Phosphatidylinositol 3-Kinase–dependent Airway Inflammation in Mice. American Journal of Respiratory and Critical Care Medicine. 177(10). 1111–1121. 105 indexed citations
10.
Hennrick, Kenneth, Suparna Nanua, Theresa Guckian Kijek, et al.. (2007). Lung Cells from Neonates Show a Mesenchymal Stem Cell Phenotype. American Journal of Respiratory and Critical Care Medicine. 175(11). 1158–1164. 97 indexed citations
11.
Nanua, Suparna, Suzanna M. Zick, Juan E. Andrade, et al.. (2006). Quercetin Blocks Airway Epithelial Cell Chemokine Expression. American Journal of Respiratory Cell and Molecular Biology. 35(5). 602–610. 39 indexed citations
12.
Nanua, Suparna, Umadevi Sajjan, Shaf Keshavjee, & Marc B. Hershenson. (2006). Absence of typical unfolded protein response in primary cultured cystic fibrosis airway epithelial cells. Biochemical and Biophysical Research Communications. 343(1). 135–143. 23 indexed citations
13.
Newcomb, Dawn C., Uma S. Sajjan, Suparna Nanua, et al.. (2005). Phosphatidylinositol 3-Kinase Is Required for Rhinovirus-induced Airway Epithelial Cell Interleukin-8 Expression. Journal of Biological Chemistry. 280(44). 36952–36961. 87 indexed citations
14.
Nanua, Suparna & Fayth K. Yoshimura. (2004). Differential Cell Killing by Lymphomagenic Murine Leukemia Viruses Occurs Independently of p53 Activation and Mitochondrial Damage. Journal of Virology. 78(10). 5088–5096. 6 indexed citations
15.
Nanua, Suparna & Fayth K. Yoshimura. (2004). Mink Epithelial Cell Killing by Pathogenic Murine Leukemia Viruses Involves Endoplasmic Reticulum Stress. Journal of Virology. 78(21). 12071–12074. 15 indexed citations
16.
Yoshimura, Fayth K., Tao Wang, & Suparna Nanua. (2001). Mink Cell Focus-Forming Murine Leukemia Virus Killing of Mink Cells Involves Apoptosis and Superinfection. Journal of Virology. 75(13). 6007–6015. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026